Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05-03

AUTHORS

C. Serrano, J. Alonso, G. Gómez-Mariano, E. Aguirre, O. Diez, N. Gadea, N. Bosch, J. Balmaña, B. Graña

ABSTRACT

Hereditary retinoblastoma (Rb) is a high penetrance autosomal dominant disease showing not only an increased risk of suffering bilateral Rb but also other second neoplasms. However, some families show a low-penetrance phenotype with reduced expressivity and incomplete penetrance of the retinoblastoma gene (RB1). Given the lack of specific guidelines for the follow-up of adult patients with hereditary Rb, the authors present a case report of a family with a low-penetrance phenotype and review the recommended surveillance in this setting, stressing the difficulties found in the genetic counselling process and follow up. Thus, since patients are at an increased risk, lifelong regular medical surveillance to detect any second malignancy at a stage that can be cured is required. In addition, avoidance of DNA-damaging agents and genetic testing should be considered for a throughout management of these families. More... »

PAGES

617

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10689-011-9445-y

DOI

http://dx.doi.org/10.1007/s10689-011-9445-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048853952

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21538077


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Counseling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Germ-Line Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation, Missense", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pedigree", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Penetrance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retinoblastoma Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Serrano", 
        "givenName": "C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles (BSD-TSI), \u00c1rea de Biolog\u00eda Celular y del Desarrollo, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413448.e", 
          "name": [
            "Unidad de Tumores S\u00f3lidos Infantiles (BSD-TSI), \u00c1rea de Biolog\u00eda Celular y del Desarrollo, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alonso", 
        "givenName": "J.", 
        "id": "sg:person.012571320022.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012571320022.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles (BSD-TSI), \u00c1rea de Biolog\u00eda Celular y del Desarrollo, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.413448.e", 
          "name": [
            "Unidad de Tumores S\u00f3lidos Infantiles (BSD-TSI), \u00c1rea de Biolog\u00eda Celular y del Desarrollo, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "G\u00f3mez-Mariano", 
        "givenName": "G.", 
        "id": "sg:person.01336240403.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336240403.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Family Cancer Unit, Medical Oncology Department, Arnau de Vilanova Hospital, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Family Cancer Unit, Medical Oncology Department, Arnau de Vilanova Hospital, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aguirre", 
        "givenName": "E.", 
        "id": "sg:person.01132141013.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132141013.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncogenetics Laboratory, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "Oncogenetics Laboratory, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diez", 
        "givenName": "O.", 
        "id": "sg:person.01176766774.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176766774.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gadea", 
        "givenName": "N.", 
        "id": "sg:person.01005724075.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005724075.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosch", 
        "givenName": "N.", 
        "id": "sg:person.01233012532.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233012532.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Balma\u00f1a", 
        "givenName": "J.", 
        "id": "sg:person.01105407254.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105407254.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411083.f", 
          "name": [
            "High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d\u2019Hebron Institute of Oncology (VHIO), University Hospital Vall d\u2019Hebron, P. Vall d\u2019Hebron 119-129, 08035, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gra\u00f1a", 
        "givenName": "B.", 
        "id": "sg:person.0602543406.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602543406.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrc2399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033037679", 
          "https://doi.org/10.1038/nrc2399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2156-6-53", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022501179", 
          "https://doi.org/10.1186/1471-2156-6-53"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1097/01.mp.0000068237.38715.d9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046197547", 
          "https://doi.org/10.1097/01.mp.0000068237.38715.d9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05-03", 
    "datePublishedReg": "2011-05-03", 
    "description": "Hereditary retinoblastoma (Rb) is a high penetrance autosomal dominant disease showing not only an increased risk of suffering bilateral Rb but also other second neoplasms. However, some families show a low-penetrance phenotype with reduced expressivity and incomplete penetrance of the retinoblastoma gene (RB1). Given the lack of specific guidelines for the follow-up of adult patients with hereditary Rb, the authors present a case report of a family with a low-penetrance phenotype and review the recommended surveillance in this setting, stressing the difficulties found in the genetic counselling process and follow up. Thus, since patients are at an increased risk, lifelong regular medical surveillance to detect any second malignancy at a stage that can be cured is required. In addition, avoidance of DNA-damaging agents and genetic testing should be considered for a throughout management of these families.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10689-011-9445-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021923", 
        "issn": [
          "1389-9600", 
          "1573-7292"
        ], 
        "name": "Familial Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "hereditary retinoblastoma", 
      "regular medical surveillance", 
      "autosomal dominant disease", 
      "second neoplasms", 
      "adult patients", 
      "second malignancies", 
      "bilateral Rb", 
      "case report", 
      "medical surveillance", 
      "low-penetrance phenotype", 
      "hereditary Rb", 
      "genetic testing", 
      "dominant disease", 
      "patients", 
      "incomplete penetrance", 
      "retinoblastoma", 
      "specific guidelines", 
      "genetic counselling process", 
      "retinoblastoma gene", 
      "risk", 
      "surveillance", 
      "reduced expressivity", 
      "DNA-damaging agents", 
      "phenotype", 
      "neoplasms", 
      "malignancy", 
      "counselling process", 
      "disease", 
      "penetrance", 
      "report", 
      "family", 
      "guidelines", 
      "agents", 
      "setting", 
      "management", 
      "testing", 
      "genes", 
      "lack", 
      "avoidance", 
      "stage", 
      "addition", 
      "expressivity", 
      "difficulties", 
      "authors", 
      "Rb", 
      "process"
    ], 
    "name": "Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up?", 
    "pagination": "617", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048853952"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10689-011-9445-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21538077"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10689-011-9445-y", 
      "https://app.dimensions.ai/details/publication/pub.1048853952"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_535.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10689-011-9445-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10689-011-9445-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10689-011-9445-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10689-011-9445-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10689-011-9445-y'


 

This table displays all metadata directly associated to this object as RDF triples.

263 TRIPLES      22 PREDICATES      95 URIs      84 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10689-011-9445-y schema:about N01a39db0943f4040a9c47d3895e974c6
2 N04c8cc6940c84eae9caab42f1548f83e
3 N2b93987e6c854fff9cf3462ecb3d971a
4 N33c43cf10e134a7c9bef668321ecf5df
5 N3b397829096f4d5f93511086af35ef70
6 N46908edc40a4434bae5e7822a278bdae
7 N63c9bbcf90a14e7f91e2c418cce1ba35
8 N70b2dfa839b84d7ca33ccc5d82453b84
9 N7a5de116ca9846678194db5bd6c79217
10 N8492253e373f4eb4997ee33a61c7cdac
11 N85ed1ef58f4a4727a317c5bf2ef0abb2
12 N9d09eebf7056492287612497d407d146
13 Na6ad86f0f16d41f994bc4eb75db4fefd
14 Nb3b28a894f364e24b5bd0d3dfac7d257
15 Nb3d8d4a2ad8746248b1439b2487b87d3
16 Nb70996f0752840949228b7bccfbd94ac
17 Nef3589baf7814f74ab4c2dae88e2abdb
18 Nf308cbe7e2c84a4b8a876193e2a5a4b2
19 Nf4cb7dec7bed4806b70b3249d7aa0c69
20 Nfcbd6563381b4672b0b3e93b6bcc3085
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N44b8bbc5d8e1499f9e2d9d54ff1eb7f6
24 schema:citation sg:pub.10.1038/nrc2399
25 sg:pub.10.1097/01.mp.0000068237.38715.d9
26 sg:pub.10.1186/1471-2156-6-53
27 schema:datePublished 2011-05-03
28 schema:datePublishedReg 2011-05-03
29 schema:description Hereditary retinoblastoma (Rb) is a high penetrance autosomal dominant disease showing not only an increased risk of suffering bilateral Rb but also other second neoplasms. However, some families show a low-penetrance phenotype with reduced expressivity and incomplete penetrance of the retinoblastoma gene (RB1). Given the lack of specific guidelines for the follow-up of adult patients with hereditary Rb, the authors present a case report of a family with a low-penetrance phenotype and review the recommended surveillance in this setting, stressing the difficulties found in the genetic counselling process and follow up. Thus, since patients are at an increased risk, lifelong regular medical surveillance to detect any second malignancy at a stage that can be cured is required. In addition, avoidance of DNA-damaging agents and genetic testing should be considered for a throughout management of these families.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N7d966622187b445cb1025239cfe2d262
34 N8f7aea4935f64464b44600a71090c500
35 sg:journal.1021923
36 schema:keywords DNA-damaging agents
37 Rb
38 addition
39 adult patients
40 agents
41 authors
42 autosomal dominant disease
43 avoidance
44 bilateral Rb
45 case report
46 counselling process
47 difficulties
48 disease
49 dominant disease
50 expressivity
51 family
52 genes
53 genetic counselling process
54 genetic testing
55 guidelines
56 hereditary Rb
57 hereditary retinoblastoma
58 incomplete penetrance
59 lack
60 low-penetrance phenotype
61 malignancy
62 management
63 medical surveillance
64 neoplasms
65 patients
66 penetrance
67 phenotype
68 process
69 reduced expressivity
70 regular medical surveillance
71 report
72 retinoblastoma
73 retinoblastoma gene
74 risk
75 second malignancies
76 second neoplasms
77 setting
78 specific guidelines
79 stage
80 surveillance
81 testing
82 schema:name Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up?
83 schema:pagination 617
84 schema:productId N0ea966e6c2264c6db9fccf07c6df8a8e
85 Nab5f3c3834214368b51cc5e63df8186f
86 Ncc3fa64463d947e2b1ee66c122649fe6
87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048853952
88 https://doi.org/10.1007/s10689-011-9445-y
89 schema:sdDatePublished 2022-05-20T07:26
90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
91 schema:sdPublisher N9bb3db4de807486ba8b7282f4e466415
92 schema:url https://doi.org/10.1007/s10689-011-9445-y
93 sgo:license sg:explorer/license/
94 sgo:sdDataset articles
95 rdf:type schema:ScholarlyArticle
96 N01a39db0943f4040a9c47d3895e974c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Polymerase Chain Reaction
98 rdf:type schema:DefinedTerm
99 N04c8cc6940c84eae9caab42f1548f83e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Pedigree
101 rdf:type schema:DefinedTerm
102 N08aa3ed7404d487eba3772ea7d4da66e rdf:first sg:person.01336240403.74
103 rdf:rest N9ee1454308de4179af8bd1996132201b
104 N0ea966e6c2264c6db9fccf07c6df8a8e schema:name doi
105 schema:value 10.1007/s10689-011-9445-y
106 rdf:type schema:PropertyValue
107 N16139b9e12dd4b84af8c9a5d123d0459 rdf:first sg:person.01105407254.85
108 rdf:rest N7855594902f843b1a652e9a283d1fe4c
109 N2b93987e6c854fff9cf3462ecb3d971a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Adult
111 rdf:type schema:DefinedTerm
112 N33c43cf10e134a7c9bef668321ecf5df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Humans
114 rdf:type schema:DefinedTerm
115 N3b397829096f4d5f93511086af35ef70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Middle Aged
117 rdf:type schema:DefinedTerm
118 N44b8bbc5d8e1499f9e2d9d54ff1eb7f6 rdf:first Nd85d232d11be4af987cac3312fc948a6
119 rdf:rest Nd44e55c5fad049bd830d21813ae3a844
120 N46908edc40a4434bae5e7822a278bdae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Genetic Counseling
122 rdf:type schema:DefinedTerm
123 N5b2312a46b964b2a98005f5c57839ee0 rdf:first sg:person.01005724075.68
124 rdf:rest Ne3e83c953c524101a4345ac71d11a721
125 N63c9bbcf90a14e7f91e2c418cce1ba35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Mutation, Missense
127 rdf:type schema:DefinedTerm
128 N70b2dfa839b84d7ca33ccc5d82453b84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Retinoblastoma Protein
130 rdf:type schema:DefinedTerm
131 N7855594902f843b1a652e9a283d1fe4c rdf:first sg:person.0602543406.11
132 rdf:rest rdf:nil
133 N7a5de116ca9846678194db5bd6c79217 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Penetrance
135 rdf:type schema:DefinedTerm
136 N7d966622187b445cb1025239cfe2d262 schema:issueNumber 3
137 rdf:type schema:PublicationIssue
138 N8492253e373f4eb4997ee33a61c7cdac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 N85ed1ef58f4a4727a317c5bf2ef0abb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Child, Preschool
143 rdf:type schema:DefinedTerm
144 N8f7aea4935f64464b44600a71090c500 schema:volumeNumber 10
145 rdf:type schema:PublicationVolume
146 N9bb3db4de807486ba8b7282f4e466415 schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 N9d09eebf7056492287612497d407d146 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Male
150 rdf:type schema:DefinedTerm
151 N9ee1454308de4179af8bd1996132201b rdf:first sg:person.01132141013.48
152 rdf:rest N9f9fa5477fb04446be3160c24819cbf4
153 N9f9fa5477fb04446be3160c24819cbf4 rdf:first sg:person.01176766774.45
154 rdf:rest N5b2312a46b964b2a98005f5c57839ee0
155 Na6ad86f0f16d41f994bc4eb75db4fefd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Follow-Up Studies
157 rdf:type schema:DefinedTerm
158 Nab5f3c3834214368b51cc5e63df8186f schema:name dimensions_id
159 schema:value pub.1048853952
160 rdf:type schema:PropertyValue
161 Nb3b28a894f364e24b5bd0d3dfac7d257 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name DNA, Neoplasm
163 rdf:type schema:DefinedTerm
164 Nb3d8d4a2ad8746248b1439b2487b87d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Young Adult
166 rdf:type schema:DefinedTerm
167 Nb70996f0752840949228b7bccfbd94ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Germ-Line Mutation
169 rdf:type schema:DefinedTerm
170 Ncc3fa64463d947e2b1ee66c122649fe6 schema:name pubmed_id
171 schema:value 21538077
172 rdf:type schema:PropertyValue
173 Nd44e55c5fad049bd830d21813ae3a844 rdf:first sg:person.012571320022.50
174 rdf:rest N08aa3ed7404d487eba3772ea7d4da66e
175 Nd85d232d11be4af987cac3312fc948a6 schema:affiliation grid-institutes:grid.411083.f
176 schema:familyName Serrano
177 schema:givenName C.
178 rdf:type schema:Person
179 Ne3e83c953c524101a4345ac71d11a721 rdf:first sg:person.01233012532.18
180 rdf:rest N16139b9e12dd4b84af8c9a5d123d0459
181 Nef3589baf7814f74ab4c2dae88e2abdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Aged, 80 and over
183 rdf:type schema:DefinedTerm
184 Nf308cbe7e2c84a4b8a876193e2a5a4b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Retinoblastoma
186 rdf:type schema:DefinedTerm
187 Nf4cb7dec7bed4806b70b3249d7aa0c69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Phenotype
189 rdf:type schema:DefinedTerm
190 Nfcbd6563381b4672b0b3e93b6bcc3085 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Female
192 rdf:type schema:DefinedTerm
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
197 schema:name Oncology and Carcinogenesis
198 rdf:type schema:DefinedTerm
199 sg:journal.1021923 schema:issn 1389-9600
200 1573-7292
201 schema:name Familial Cancer
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01005724075.68 schema:affiliation grid-institutes:grid.411083.f
205 schema:familyName Gadea
206 schema:givenName N.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005724075.68
208 rdf:type schema:Person
209 sg:person.01105407254.85 schema:affiliation grid-institutes:grid.411083.f
210 schema:familyName Balmaña
211 schema:givenName J.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105407254.85
213 rdf:type schema:Person
214 sg:person.01132141013.48 schema:affiliation grid-institutes:None
215 schema:familyName Aguirre
216 schema:givenName E.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132141013.48
218 rdf:type schema:Person
219 sg:person.01176766774.45 schema:affiliation grid-institutes:grid.411083.f
220 schema:familyName Diez
221 schema:givenName O.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176766774.45
223 rdf:type schema:Person
224 sg:person.01233012532.18 schema:affiliation grid-institutes:grid.411083.f
225 schema:familyName Bosch
226 schema:givenName N.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233012532.18
228 rdf:type schema:Person
229 sg:person.012571320022.50 schema:affiliation grid-institutes:grid.413448.e
230 schema:familyName Alonso
231 schema:givenName J.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012571320022.50
233 rdf:type schema:Person
234 sg:person.01336240403.74 schema:affiliation grid-institutes:grid.413448.e
235 schema:familyName Gómez-Mariano
236 schema:givenName G.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336240403.74
238 rdf:type schema:Person
239 sg:person.0602543406.11 schema:affiliation grid-institutes:grid.411083.f
240 schema:familyName Graña
241 schema:givenName B.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602543406.11
243 rdf:type schema:Person
244 sg:pub.10.1038/nrc2399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033037679
245 https://doi.org/10.1038/nrc2399
246 rdf:type schema:CreativeWork
247 sg:pub.10.1097/01.mp.0000068237.38715.d9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046197547
248 https://doi.org/10.1097/01.mp.0000068237.38715.d9
249 rdf:type schema:CreativeWork
250 sg:pub.10.1186/1471-2156-6-53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022501179
251 https://doi.org/10.1186/1471-2156-6-53
252 rdf:type schema:CreativeWork
253 grid-institutes:None schema:alternateName Family Cancer Unit, Medical Oncology Department, Arnau de Vilanova Hospital, Lleida, Spain
254 schema:name Family Cancer Unit, Medical Oncology Department, Arnau de Vilanova Hospital, Lleida, Spain
255 rdf:type schema:Organization
256 grid-institutes:grid.411083.f schema:alternateName High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, P. Vall d’Hebron 119-129, 08035, Barcelona, Spain
257 Oncogenetics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
258 schema:name High Risk and Cancer Prevention Unit, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, P. Vall d’Hebron 119-129, 08035, Barcelona, Spain
259 Oncogenetics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
260 rdf:type schema:Organization
261 grid-institutes:grid.413448.e schema:alternateName Unidad de Tumores Sólidos Infantiles (BSD-TSI), Área de Biología Celular y del Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
262 schema:name Unidad de Tumores Sólidos Infantiles (BSD-TSI), Área de Biología Celular y del Desarrollo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
263 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...